Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer

Clinical nuclear medicine

Volumn 41, Issue 9, 2016, Pages e417-e419

  Queiroz, Marcelo A ^a   Viana, Publio ^b   Santos, Allan ^b   Bastos, Diogo ^b   Etchebehere, Elba ^b   Cerri, Giovanni ^b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEDRONATE TECHNETIUM TC 99M; MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; BLOOD; CASE REPORT; DIAGNOSTIC IMAGING; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROSTATECTOMY; PROSTATIC NEOPLASMS; SECONDARY;

ADENOCARCINOMA; ANTIGENS, SURFACE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MEDIASTINUM; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE;

EID: 84973301149     PISSN: None     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001264     Document Type: Article

References (0)